Schur P H, Marcus-Bagley D, Awdeh Z, Yunis E J, Alper C A
Department of Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA 02115.
Arthritis Rheum. 1990 Jul;33(7):985-92. doi: 10.1002/art.1780330710.
Previous studies of patients with systemic lupus erythematosus (SLE) have shown an increased frequency of certain major histocompatibility complex (MHC) markers, including HLA-DR2, DR3, and C4AQ0 (C4A-null), in Caucasian patients. However, most of these studies were of randomly selected, unrelated patients; families were not included, and haplotypes were not determined. In order to define more accurately the possible role of MHC genes in lupus susceptibility, HLA-A, B, C, and DR, as well as BF, C2, C4A, C4B, and GLO, markers were determined in 62 Caucasian patients of known ethnic background, and in the members of their families. The distributions of extended haplotypes (fixed combinations of HLA-B, DR, and complotype alleles), fragments thereof, and individual alleles were determined in SLE patients and controls. The MHC distributions in all patients were compared with haplotypes in a normal Caucasian population. There were no statistically significant differences between the frequencies of any MHC marker, fragment, or extended haplotype in the patients compared with the controls. The patients were categorized into 2 groups of European ancestry (English/Irish; other Europeans), and each group was compared with a group of ethnically matched controls. There was a statistically significantly increased frequency of the alleles C4AQ0 and DR3 and the complotype SC01 in SLE patients of English/Irish descent as compared with ethnically matched controls. The increase in C4AQ0 and DR3 could be accounted for by the fact that they were part of the extended haplotype [HLA-B8;SC01;DR3] and/or its fragment (SC01;DR3). No increase in any MHC marker was observed in the other patients.(ABSTRACT TRUNCATED AT 250 WORDS)
先前对系统性红斑狼疮(SLE)患者的研究表明,在白种人患者中,某些主要组织相容性复合体(MHC)标记物的频率增加,包括HLA - DR2、DR3和C4AQ0(C4A缺失)。然而,这些研究大多针对随机选择的、无亲缘关系的患者;未纳入家庭,也未确定单倍型。为了更准确地确定MHC基因在狼疮易感性中的可能作用,对62名已知种族背景的白种人患者及其家庭成员进行了HLA - A、B、C、DR以及BF、C2、C4A、C4B和GLO标记物的检测。在SLE患者和对照中确定了扩展单倍型(HLA - B、DR和补体型等位基因的固定组合)、其片段以及单个等位基因的分布。将所有患者的MHC分布与正常白种人群的单倍型进行比较。与对照相比,患者中任何MHC标记物、片段或扩展单倍型的频率均无统计学显著差异。患者被分为两组欧洲血统(英格兰/爱尔兰;其他欧洲人),并将每组与一组种族匹配的对照进行比较。与种族匹配的对照相比,英格兰/爱尔兰血统的SLE患者中,等位基因C4AQ0和DR3以及补体型SC01的频率在统计学上显著增加。C4AQ0和DR3的增加可归因于它们是扩展单倍型[HLA - B8;SC01;DR3]和/或其片段(SC01;DR3)的一部分。在其他患者中未观察到任何MHC标记物增加。(摘要截短于250字)